Patents by Inventor Shauna Andersson

Shauna Andersson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FITUSIRAN FOR THE TREATMENT OF HEMOPHILIA A AND B IN PEDIATRIC PATIENTS
    Publication number: 20260240891
    Abstract: The present disclosure provides methods and compositions for treating pediatric patients with hemophilia A or B with or without inhibitors.
    Type: Application
    Filed: June 8, 2023
    Publication date: August 20, 2026
    Inventors: Shauna ANDERSSON, Pratik R BHAGUNDE, Sajida IQBAL, Pranav PATEL, Stacey POLOSKEY, Fadi SHAMMAS
  • TREATMENT OF HEMOPHILIA A WITH FITUSIRAN
    Publication number: 20260185097
    Abstract: The present disclosure provides methods for using fitusiran to treat hemophilia A in patients who have previously been treated with emicizumab.
    Type: Application
    Filed: March 12, 2026
    Publication date: July 2, 2026
    Inventors: Shauna ANDERSSON, Viridiana Cano, Ekta Seth Chhabra, Sajida Iqbal, Salim Kichou, Barbara Kittner, Laurel Menapace
  • METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA
    Publication number: 20260014188
    Abstract: The present disclosure provides using a double-stranded oligonucleotide compound as a novel therapy to improve the quality of life and joint function of patients with hemophilia A and hemophilia B.
    Type: Application
    Filed: September 17, 2025
    Publication date: January 15, 2026
    Inventors: Baisong MEI, Shauna ANDERSSON, Qifeng YU, Pronabesh DASMAHAPATRA
  • Fitusiran for Use in Improving Patient-Reported Outcome in Hemophilia Patients
    Publication number: 20250064842
    Abstract: The present disclosure provides using a double-stranded oligonucleotide compound as a novel therapy to improve the patient reported outcomes and quality of life of patients with hemophilia A or hemophilia B.
    Type: Application
    Filed: December 22, 2022
    Publication date: February 27, 2025
    Applicant: Genzyme Corporation
    Inventors: Shauna Andersson, Jose Bartelt-Hofer, Pronabesh Dasmahapatra
  • TREATMENT OF HEMOPHILIA WITH FITUSIRAN
    Publication number: 20240027478
    Abstract: The present disclosure provides a method that aims to maintain a favorable benefit-risk balance for patients with hemophilia A or B with or without inhibitors treated with fitusiran.
    Type: Application
    Filed: December 6, 2021
    Publication date: January 25, 2024
    Applicant: Genzyme Corporation
    Inventors: Stacey Poloskey, Shauna Andersson, Pratik R. Bhagunde, Yue Cui, Sajida Iqbal, Baisong Mei
  • Treatment of Hemophilia with Fitusiran
    Publication number: 20240000744
    Abstract: The present disclosure provides methods for using fitusiran to treat patients with hemophilia A or hemophilia B.
    Type: Application
    Filed: June 8, 2023
    Publication date: January 4, 2024
    Applicant: Genzyme Corporation
    Inventors: Shauna Andersson, Baisong Mei, Fadi Shammas, Christian Sussebach
  • METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA
    Publication number: 20210393669
    Abstract: The present disclosure provides using a double-stranded oligonucleotide compound as a novel therapy to improve the quality of life and joint function of patients with hemophilia A and hemophilia B.
    Type: Application
    Filed: June 22, 2021
    Publication date: December 23, 2021
    Applicant: Genzyme Corporation
    Inventors: Baisong Mei, Shauna Andersson, Qifeng Yu, Pronabesh DasMahapatra